CELLIPSE is a drug discovery company based in Grenoble, France dedicated to bringing innovative therapies to cancer patients and healthcare professionals. We are building a pipeline of small molecules targeting the cytoskeleton (i.e. microtubules and actin filaments) based on our « cell to drug discovery » approach.
View Top Employees from CELLIPSEWebsite | http://www.cellipse.com |
Revenue | $400000 |
Employees | 4 (0 on RocketReach) |
Founded | 2013 |
Address | 7 Parvis Louis Néel, Grenoble, Auvergne-Rhone-Alpes 38040, FR |
Technologies |
JavaScript,
HTML,
Twitter
+386 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Drug Manufacturing & Research |
SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 54 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular CELLIPSE employee's phone or email?
The CELLIPSE annual revenue was $400000 in 2024.
CELLIPSE is based in Grenoble, Auvergne-Rhone-Alpes.
The NAICS codes for CELLIPSE are [325, 54, 3254, 541, 32, 32541].
The SIC codes for CELLIPSE are [283, 2834, 28].